Neurotoxicity of interferon-? in melanoma therapy
- 1 August 1998
- Vol. 83 (3), 482-489
- https://doi.org/10.1002/(sici)1097-0142(19980801)83:3<482::aid-cncr17>3.0.co;2-s
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.Journal of Clinical Oncology, 1996
- Neurotoxicity of intraventricularly administered alpha-interferon for leptomeningeal diseaseCancer, 1991
- Persistent neurotoxicity of systemically administered interferon‐alphaNeurology, 1991
- Letters to the Editor: Does Alpha-interferon in conjunction with radiotherapy increase the risk of complications in the central nervous system?Annals of Oncology, 1990
- Interferon-related mental deterioration and behavioral changes in patients with renal cell carcinomaEuropean Journal of Cancer and Clinical Oncology, 1990
- Interferon-induced organic mental disorders associated with unsuspected pre-existing neurologic abnormalitiesJournal of Neuro-Oncology, 1988
- Comparison of Intramuscular and Intravenous Recombinant Alpha-2 Interferon in Melanoma and Other CancersAnnals of Internal Medicine, 1985
- Collaborative phase I-II study of recombinant DNA-produced leukocyte interferon (clone A) in metastatic breast cancer, malignant lymphoma, and multiple myelomaAmerican Journal Of Medicine, 1984
- Central nervous system toxicity of interferonBritish Journal of Cancer, 1983
- A Comparison of Prognostic Factors and Surgical Results in 1,786 Patients with Localized (Stage I) Melanoma Treated in Alabama, USA, and New South Wales, AustraliaAnnals of Surgery, 1982